Brett L. Swanson

Brett’s areas of expertise are managed Medicare healthcare programs and prescription drugs. He conducts firm research and develops related tools for Milliman consultants and clients. He has assisted clients with:

• Medicare contracting
• Feasibility studies
• Risk adjustment
• Medical cost estimates and projections
• Product development
• Experience analysis, trend analysis
• Mergers and acquisitions
• Bid development and support
• Benchmarking
• Employer group waiver plan underwriting support
• Assessments of regulatory impacts

Additionally, his vast knowledge of prescription drugs includes:

• Benefit design
• Formulary analytics
• Cost guidelines
• Cost management for commercial and Medicare populations
• Evaluation of strategic partnerships for prescription drug acquisition

Brett has a comprehensive understanding of the Medicare Advantage program and its impact on employers, Medicare Advantage prescription drug plans, and private prescription drug plans. Brett has advised chronic care special needs plans, dual-eligible special needs plans, general enrollment plans, and standalone prescription drug plans.

Brett is the developer and lead consultant of the Milliman Medicare Advantage Competitive Value Added Tool that is used across the Medicare Advantage industry and is designed to evaluate the relative competitive value of benefits and premiums offered by Medicare Advantage organizations.

In addition to managed Medicare and pharmacy, Brett has experience with other managed care clients. He has assisted clients with all aspects of health insurance, including plan design, pricing, cost and utilization benchmarking, rate model development, rating system implementation, underwriting, PBM contracting, risk and experience analysis, financial projections, and liability estimation.